Three week iloprost-therapy as an effective treatment of PSS - Case report and literature reference review;Iloprostgabe uber 21 Tage als wirksame Therapie bei der progressiven systemischen Sklerodermie - Fallbeschreibung und Literaturubersicht

Zeitschrift fur Rheumatologie

Volumn 57, Issue 2, 1998, Pages 118-124

  Riemekasten, G ^a   Jepsen, H ^a   Burmester, G R ^a   Hiepe, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Iloprost; Lung function; Prostacyclin; Raynaud's syndrome; Systemic sclerosis

Indexed keywords

C REACTIVE PROTEIN; ILOPROST; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; ELECTRON SPIN RESONANCE; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; MIDDLE AGED; REVIEW;

CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ILOPROST; MIDDLE AGED; SCLERODERMA, SYSTEMIC; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032041297     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050070     Document Type: Article

References (24)

1. Arpaia G, Cimminiello C, Sardina M, Rossi F, Aloisio M, Curri SB, Bonfardeci G (1995) Microcirculatory effects of iloprost in patients with suspected secondary Raynaud phenomenon. Vasc Surg 29:37-42
2. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langlehen D, Keller CA, Uretsky BF, Clayton LM, Jobsis MM, Blackburn SD, Jr., Shortino D, Crow JW (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334:296-302
3. Belch JJ, Capell HA, Cooke ED, Kirby JD, Lau CS, Madhok R, Murphy E, Steinberg M (1995) Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study. Ann Rheum Dis 54:197-200
4. Belch JJF, Saniabadi A, Dickson R, Sturrock RD, Forbes CD (1987) Effect of iloprost on white cell behavior. In: Prostacyclin and its stable analogue iloprost, Gryglewski RG, Stock G (eds) Springer-Verlag, Berlin, Heidelberg, pp 97
5. Cordioli E, Virgilio S, Ghirardi R, Martinelli M (1992) Effects of long-term iloprost therapy on Raynaud's phenomenon in progressive systemic sclerosis (ital.). Minerva Med 83:739-744
6. Creutzig A (1994) Prostaglandine bei arteriellen Durchblutungsstörungen. Internist Prax 34:265-270
7. Crutchley DJ, Conanan LB, Que BG (1994) Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells. J Pharmacol Exp Ther 271:446-451
8. De la Mata J, Gomez Sanchez MA, Aranzana M, Gomez Reino JJ (1994) Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum 37:1528-1533
9. Diehm C (1994) Bedeutung der Prostaglandine bei arteriellen Durchblutungsstörungen. Internist Berl 35:764-770
10. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB (1994) Induction of vascular endothelial growth factor expresson by postaglandin E2 and E1 in osteoblasts. J Clin Invest 93:2490-2496
11. Kahaleh B, Matucci Cerinic M (1995) Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 38:1-4
12. Kyle MV, Belcher G, Hazleman BL (1992) Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. J Rheumatol 19:1403-1406
13. Lau CS, Belch JJ, Madhok R, Cappell H, Herrick A, Jayson M, Thompson JM (1993) A randomised, double-blind study of cicaprost, an oral prostacyclin analogue, in the treatment of Raynaud's phenomenon secondary to systemic sclerosis. Clin Exp Rheumatol 11:35-40
14. Müller B, Schmidtke M (1987) Microvascular effects of iloprost in the hamster cheek pouch. Adv Prostaglandin Thromboxane Leukot Res 17A:455-458
15. Müller B, Schmidtke M, Witt W (1987) Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch. Prostaglandins Leukot Med 29:187-198
16. Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TG, Kirby JD (1989) Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study. BMJ 298:561-564
17. Rodnan RP, Myerowitz RL, Justh GO (1980) Morphologic changes in digital arteries of progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine 59:393-408
18. Stürzebecher CS, Losen W (1987) Effect of iloprost on platelet activation in vitro. In: Prostacyclin and its stable analogue iloprost, Gryglewski RG, Stock G (eds) Springer-Verlag, Berlin, Heidelberg, pp 39
19. Tanner SB, Darton K, Watson HR, Cauka ME, Stevens W, Gendi M, Black CM (1991) Long-term follow-up of iloprost therapy for secondary Raynaud's phenomenom using self-report data and infra-red thermography. Arthritis Rheum 34:S52(Abstract)
20. Torley HI, Madhok R, Capell HA, Brouwer RM, Maddison PJ, Black CM, Englert H, Dormandy JA, Watson HR (1991) A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis 50:800-804
21. Watson HR, Belcher G (1991) Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon. Ann Rheum Dis 50:359-361
22. Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP (1992) Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 19:1407-1414
23. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA, Jr., Steen VD, Varga J, Jimenez S, Mayes M, et al (1994) Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 120:199-2-06
24. Yardumian DA, Isenberg DA, Rustin M, Belcher G, Snaith ML, Dowd PM, Machin SJ (1988) Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue. Br J Rheumatol 27:220-226